|
![]() |
|||
|
||||
OverviewCovers the latest research on a sensitive and controversial topic in a professional and well researched manner. Provides practical outlook as well as model guidelines and software tools that should be of interest to people who use the software tools described and those who do not. Related title by Co-author Geert Molenbergh has sold more than 3500 copies world wide. Provides dual viewpoints: from scientists in the industry as well as regulatory authorities. Full Product DetailsAuthor: Tomasz Burzykowski , Geert Molenberghs , Marc BuysePublisher: Springer Imprint: Springer Dimensions: Width: 23.40cm , Height: 2.30cm , Length: 15.60cm Weight: 0.608kg ISBN: 9780387500867ISBN 10: 0387500863 Pages: 436 Publication Date: 15 February 2009 Audience: General/trade , General Format: Undefined Publisher's Status: Unknown Availability: Out of stock ![]() Table of ContentsReviews<p>From the reviews: <p> A strength of this book is its comprehensive and up-to-date presentation of issues pertinent to the evaluation of surrgoate endpoints...This book makes an important contribution to the clinical trials literature... Journal of Biopharmaceutical Statistics, 2006<p> Many of the chapters deal with real-life data examples and studies involving surrogate outcomes, many written by authors who were directly involved in these studies...The editors have written nice background sections...until a more concise manuscript on this topic is written, this book will remain the most important resource for biostatisticians and researchers in this area. Debajyoti Sinha for the Journal of the American Statistical Association, December 2006<p> This book is a reflection of the ongoing debate on the definition and use of surrogate markers...I see the book as an invitation to join the debate. There is much work to be done and reading the book might inspire many to participate. It wil Author InformationTab Content 6Author Website:Countries AvailableAll regions |